Category: Enzymes
Global Enzymes
-
Global Specialty Enzymes Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Digestive Enzyme Supplements Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to 2031
... Growth Opportunities, and Outlook to 2031 The Global Digestive Enzyme Supplements Market Research Report is a comprehensive and insightful analysis designed to assist stakeholders, industry professionals, and decision-makers in identifying Digestive Enzyme Supplements market potential ... Read More
-
Animal Growth Promoters Market by Type (Acidifiers, Antibiotics, Enzymes), Form (Feed Additives, Injectable Growth Promoters, Water Additives), Animal Type - Global Forecast 2024-2030
... in 2023 and expected to reach USD 16.47 billion in 2024, at a CAGR 8.59% to reach USD 27.11 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Animal ... Read More
-
Food Authenticity Market by Type (DNA Sequencing/Barcoding, Immunoassay-Based/Enzyme-Linked Immunosorbent Assay (ELISA), Isotope Methods), Category (Adulteration Tests, Allergen Testing, False Labelling), Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 8.24 billion in 2024, at a CAGR 6.75% to reach USD 12.23 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Enzyme Replacement Therapy Market by Therapeutic Condition (Fabry Disease, Gaucher Disease, Mucopolysaccharidosis), Enzyme Type (Agalsidase Beta, Alglucosidase Alfa, Galsulfase), Route of Administration, End-User - Global Forecast 2024-2030
... at USD 8.09 billion in 2023 and expected to reach USD 8.87 billion in 2024, at a CAGR 9.80% to reach USD 15.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Renal Biomarkers Market by Marker Type (Blood Urea Nitrogen, Creatinine, Cystatin C), Assay Platform Type (Enzymatic Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Turbidimetric Immunoassay), Application, End-User - Global Forecast 2024-2030
... estimated at USD 1.33 billion in 2023 and expected to reach USD 1.43 billion in 2024, at a CAGR 7.72% to reach USD 2.24 billion by 2030. Global Renal Biomarkers Market FPNV Positioning Matrix The ... Read More
-
Cardiac Biomarker Market by Type (Brain Natriuretic Peptide or NT-proBNP, Creatine Kinase, Ischemia Modified Albumin), Location of Testing (Laboratory Testing, Point of Care Testing), Application - Global Forecast 2024-2030
... estimated at USD 4.62 billion in 2023 and expected to reach USD 5.31 billion in 2024, at a CAGR 14.90% to reach USD 12.24 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
White Biotechnology Market by Product (Biochemicals, Biofuels, Biomaterials), Application (Bioenergy, Food & Feed Additives, Personal Care & Household Products) - Global Forecast 2024-2030
... 2023 and expected to reach USD 232.78 billion in 2024, at a CAGR 3.18% to reach USD 281.20 billion by 2030. Global White Biotechnology Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Esoteric Testing Market by Technology (Chemiluminescence Immunoassay, DNA Sequencing, Enzyme-Linked Immunosorbent Assay), Type (Endocrinology Testing, Genetics Testing, Immunology Testing), End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 30.81 billion in 2024, at a CAGR 12.53% to reach USD 63.19 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Esoteric ... Read More
-
Pompe Disease Market by Therapy Type (Enzyme, Substrate), Molecule Type (Biologics, Small Molecules), Dosage Form, Route of Administration - Global Forecast 2024-2030
... and expected to reach USD 1.59 billion in 2024, at a CAGR 5.61% to reach USD 2.21 billion by 2030. Global Pompe Disease Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Food Allergen Testing Market by Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR)), Type (Allergy Blood Test, Food Elimination Diet Test, Oral Food Challenge Test), Source, Food Tested - Global Forecast 2024-2030
... Allergen Testing Market size was estimated at USD 842.38 million in 2023 and expected to reach USD 902.78 million in 2024, at a CAGR 7.40% to reach USD 1,388.99 million by 2030. FPNV Positioning Matrix ... Read More
-
Fabry Disease Treatment Market by Treatment Type (Chaperone Treatment, Enzyme Replacement Therapy, Organ-Specific Treatment), Drugs (Agalsidase Beta, Migalastat, Pipeline Drugs), Route of Administration - Global Forecast 2024-2030
... at USD 2.50 billion in 2023 and expected to reach USD 2.71 billion in 2024, at a CAGR 8.47% to reach USD 4.41 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Molecular Biology Enzymes & Kits & Reagents Market by Type (Enzymes, Kits, Reagents), Application (Drug Discovery & Development, Epigenetics, Polymerase Chain Reaction), End-User - Global Forecast 2024-2030
... Market size was estimated at USD 19.14 billion in 2023 and expected to reach USD 21.35 billion in 2024, at a CAGR 11.88% to reach USD 42.02 billion by 2030. FPNV Positioning Matrix The FPNV ... Read More
-
Carbohydrase Market by Type (Amylases, Cellulases, Lactase), Application (Animal Feed, Food & Beverage, Pharmaceutical) - Global Forecast 2024-2030
... 3.60 billion in 2024, at a CAGR 7.03% to reach USD 5.49 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Carbohydrase Market. It offers a comprehensive assessment of ... Read More
-
Immunoprotein Diagnostic Testing Market by Technology (Enzyme-Linked Immunoassay, Immunofluorescence Assay, Radioimmunoassay), Immunoprotein Type (C-reactive Protein, Complement System Protein, Immunoglobulin), Application, End-User - Global Forecast 2024-2030
... 8.81 billion in 2023 and expected to reach USD 9.41 billion in 2024, at a CAGR 6.92% to reach USD 14.07 billion by 2030. Global Immunoprotein Diagnostic Testing Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Lysosomal Storage Diseases Market by Disease Type (Fabry Diseases, Gaucher's Diseases, Mucopolysaccharidosis), Type of Therapy (Enzyme Replacement Therapy, Stem Cell Therapy, Substrate Reduction Therapy), End User - Global Forecast 2024-2030
... size was estimated at USD 9.31 billion in 2023 and expected to reach USD 9.98 billion in 2024, at a CAGR 7.48% to reach USD 15.43 billion by 2030. FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Gaucher Disease Treatment Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3), Treatment (Enzyme Replacement Therapy, Substrate Reduction Therapy), Diagnosis, Distribution Channel - Global Forecast 2024-2030
... Treatment Market size was estimated at USD 1.26 billion in 2023 and expected to reach USD 1.32 billion in 2024, at a CAGR 5.18% to reach USD 1.80 billion by 2030. FPNV Positioning Matrix The ... Read More
-
Arbovirus Testing Market by Type (Enzyme-linked Immunosorbent Assays (ELISAs), RT-PCR Assays), Component (Instruments & Equipments, Laboratory Consumables, Software & Data Management Solutions), Indication, End-User - Global Forecast 2024-2030
... at USD 1.24 billion in 2023 and expected to reach USD 1.31 billion in 2024, at a CAGR 5.81% to reach USD 1.85 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Curcumin Market by Extraction Process (Enzyme-Assisted Extraction, Extraction With Supercritical Liquid, Maceration), Application (Food & Beverage, Pharmaceuticals, Skincare & Cosmetics) - Global Forecast 2024-2030
... 2023 and expected to reach USD 202.15 million in 2024, at a CAGR 9.81% to reach USD 349.54 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Curcumin Market. ... Read More
-
Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis A, Hepatitis B, Hepatitis C), Technology (Enzyme-Linked Immunosorbent Assay, Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction), End-User - Global Forecast 2024-
... size was estimated at USD 3.53 billion in 2023 and expected to reach USD 3.71 billion in 2024, at a CAGR 5.48% to reach USD 5.13 billion by 2030.The hepatitis test solutions/ diagnosis are used ... Read More
-
CRISPR Gene Editing Market by Product (Enzymes, Kits, Libraries), Services (Cell Line Engineering, gRNA design, Screening), Technology, Application, End User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 4.18 billion in 2024, at a CAGR 11.65% to reach USD 7.72 billion by 2030. Global CRISPR Gene Editing Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Protein Labeling Market by Product (Kits, Reagents, Services), Labeling Method (Bioorthogonal Labeling, In Vitro Labeling Methods, In Vivo Labeling Methods), Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 2.57 billion in 2024, at a CAGR 10.57% to reach USD 4.70 billion by 2030. Global Protein Labeling Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Antinuclear Antibody Testing Market by Product (Reagents & Assay Kits, Services, Software), Technique (Enzyme-linked immunosorbent assay (ELISA), Indirect immunofluorescent (IIF), Multiplex immunoassay), Technology, Indication, End-User - Global Forecast
... was estimated at USD 1.77 billion in 2023 and expected to reach USD 1.95 billion in 2024, at a CAGR 10.49% to reach USD 3.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Glycomics/Glycobiology Market by Product (Carbohydrates, Enzymes, Instruments), Application (Cell Biology, Disease Diagnostics, Drug Discovery & Development), End-User - Global Forecast 2024-2030
... to reach USD 3.90 billion in 2024, at a CAGR 11.87% to reach USD 7.67 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Glycomics/Glycobiology Market. It offers a ... Read More
-
Hunter Syndrome Treatment Market by Treatment (Enzyme Replacement Therapy, Hematopoietic Stem Cell Transplant), End User (Clinics, Home Healthcare, Hospitals) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 1.17 billion in 2024, at a CAGR 8.06% to reach USD 1.87 billion by 2030. Global Hunter Syndrome Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
Research Assistance
